Viewing Study NCT00834093


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2026-01-03 @ 12:59 AM
Study NCT ID: NCT00834093
Status: COMPLETED
Last Update Posted: 2023-06-28
First Post: 2009-02-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Sponsor:
Organization: